Delhi/NCR:

MOHALI:

Dehradun:

BATHINDA:

BRAIN ATTACK:

Corporate Announcements

Announcements & Disclosures

Newspaper Publications

Newspaper Advertisement of Financial Results for quarter and half year ended September 30, 2023
Newspaper Publication – Notice of 22nd Annual General Meeting and E-voting information
Newspaper Publication - Information regarding 22nd Annual General Meeting and Record Date
Newspaper Advertisement of Financial Results for quarter ended June 30, 2023
Newspaper Publication - Notice of Postal Ballot, July 2023
Newspaper Advertisement of Financial Results for quarter and financial year ended March 31, 2023
Newspaper Advertisement Nine Months ended Financial Results – Dec 31, 2022
Newspaper Advertisement Six Months ended Results – Sep 30, 2022
Newspaper Advertisement –Notice of 21st AGM
Newspaper Advertisement – Intimation of 21st AGM/ Email Registration
Newspaper Advertisement Quarterly Financial Results - June 30, 2022
Newspaper Advertisement of Financial Results – March 31, 2022
Newspaper Publications – Postal Ballot, April 2022
Newspaper Advertisement Nine Months Ended Results – Dec 31, 2021
Newspaper Advertisement Six Months Ended Results – Sep 30 2021
Newspaper Publications - Postal ballot
Newspaper Advertisement - Notice of 20th AGM
Newspaper Advertisement – Intimation of 20th AGM/ Email Registration
Newspaper Advertisement- Quarterly Financial Results- June 30, 2021
Newspaper Advertisement of Financial Results - March 31, 2021
Newspaper Advertisement- Quarterly Financial Results- December 31, 2020
Notice Board Meeting- 28.01.2021
Newspaper Advertisement for Email Registration
Notice Board Meeting-31-10-2020
Newspaper Advertisement for Notice of 19th AGM

AGM Proceedings

Proceeding of AGM-September 27, 2023
Proceeding of AGM-September 26, 2022
Proceeding of AGM-September 29, 2021
Proceeding of AGM-September 29, 2020

Outcome of Board Meeting

Outcome of Board Meeting held on January 31, 2024
Outcome of Board Meeting held on November 6, 2023
Outcome of Board Meeting held on August 7, 2023
Outcome of Board Meeting held on May 16, 2023
Outcome of Board Meeting held on February 02, 2023
Outcome of Board Meeting held on November 01, 2022
Outcome of Board Meeting held on August 10, 2022
Outcome of Board Meeting held on May 25, 2022
Outcome of Board Meeting held on Feb 12, 2022
Outcome of Board Meeting held on November 12, 2021
Outcome of Board Meeting held on August 10, 2021
Outcome of Board Meeting held on May 28, 2021
Update on Board Outcome May 28, 2021
Board Meeting Outcome & Investor Call held on February 06, 2021
Outcome of Board Meeting held on November 11, 2020
Outcome of Board Meeting held on September 1, 2020

Quarterly Corporate Governance Report

Corporate Governance Report – December 31, 2023
Corporate Governance Report – September 30, 2023
Corporate Governance Report – June 30, 2023
Corporate Governance Report - June 30, 2023
Corporate Governance Report - March 31, 2023
Corporate Governance Report – December 31, 2022
Corporate Governance Report – September 30, 2022
Corporate Governance Report - June 30, 2022
Corporate Governance Report - March 31, 2022
Corporate Governance Report - December 31, 2021
Corporate Governance Report - September 30, 2021
Corporate Governance Report – June 30, 2021
Corporate Governance Report - March 31, 2021
Corporate Governance Report - December 31, 2020
Corporate Governance Report September 30, 2020

Shareholding Pattern

Shareholding Pattern – December 31, 2023
Shareholding Pattern – September 30, 2023
Shareholding Pattern – June 30, 2023
Shareholding Pattern – March 31, 2023
Shareholding Pattern – December 31, 2022
Shareholding Pattern – September 30, 2022
Shareholding Pattern - June 30, 2022
Shareholding Pattern - March 31, 2022
Shareholding Pattern - December 31, 2021
Shareholding Pattern - September 30, 2021
Shareholding Pattern June 30, 2021
Shareholding Pattern Mar 31, 2021
Shareholding Pattern December 31, 2020
Shareholding Pattern– Sept, 2020

Others

Closure of Trading window – April 1, 2024
SE Intimation for Re-appointment of Mr. Mahendra Gumanmalji Lodha and Mr. Michael Thomas Neeb as Independent Directors
ESOP Allotment - March 18, 2024
Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
SE Intimation for Agreement between the Company and Touch Healthcare Private Limited & Others in respect of the ongoing arbitration proceedings
SE Intimation for Issuance of Corporate Guarantee by Crosslay Remedies Limited, a wholly-owned subsidiary
SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
SE Intimation for Acquisition of Land Parcel allotted through e-auction for setting up of 500+ bedded Hospital in Lucknow
SE Intimation for Completion of Acquisition of 100% equity stake in Alexis Multi-Speciality Hospital Private Limited
SE Intimation - Presentation for Investor Conference - February 14, 2024
SE Intimation for transcript of Earnings Call held on February 1, 2024.
SE Intimation for Update on acquisition of equity stake in Alexis Multi-Speciality Hospital Private Limited
SE Intimation for Acquisition of 100% equity stake in Alexis Multi-Speciality Hospital Private Limited
SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
ESOP Allotment – January 30, 2024
Board Meeting Intimation – January 31, 2024
SE Intimation for Incorporation of Max Healthcare Foundation
Compliance under Regulation 76 of the SEBI (DP) Regulations – December 31, 2023
Compliance under Regulation 74(5) of the SEBI (DP) Regulations – December 31, 2023
Closure of Trading window – January 1, 2024
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – December 19, 2023
Share Purchase Agreement to Acquire 100% stake in Starlit Medical Centre Private Limited and issuance of Corporate Guarantee
SE Intimation for disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Disclosure of Related Party Transactions for the half year ended September 30, 2023
SE Intimation for transcript of Earnings Call held on November 7, 2023.
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – November 6, 2023.
ESOP Allotment – November 6, 2023
Board Meeting Intimation – November 6, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 25, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 19, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 17, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 16, 2023
Compliance under Regulation 76 of the SEBI (DP) Regulations – September 30, 2023
Compliance under Regulation 74(5) of the SEBI (DP) Regulations – September 30, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – October 4, 2023
Closure of Trading window – October 1, 2023
SE Intimation for Amendment in Articles of Association
Voting Results and Scrutinizer’s Report – 22nd AGM
SE Intimation for change in Senior Management Personnel
ESOP Allotment – September 13, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – September 11, 2023
SE Intimation for writ petition filed by the Company against State of Punjab and Others
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – September 1, 2023
SE Intimation for communication to members - Deduction of tax at source on final dividend
SE Intimation of Annual General Meeting and Record Date
SE Intimation for Appointment of Ms. Amrita Gangotra as an Additional Director (Non-Executive and Independent Woman Director)
SE Intimation – Presentation for Investor Conference
SE Intimation for disclosure of continuing events
SE Intimation for transcript of Earnings Call held on August 8, 2023
Intimation for Earnings Call audio recording - August 8, 2023
ESOP Allotment - August 7, 2023
Board Meeting Intimation – August 7, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others – July 27, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others
SE Intimation for Newspaper Publication – Notice of Postal Ballot
SE Intimation for Notice of Postal Ballot
Compliance under Regulation 76 of the SEBI (DP) Regulations – June 30, 2023
Compliance under Regulation 74(5) of the SEBI (DP) Regulations – June 30, 2023
Closure of Trading Window – June 30, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others - June 02, 2023
SE Intimation for Appointment of Mr. Narayan K. Seshadri as an Additional Director (Non-Executive and Non-Independent)
Grant of options under Max Healthcare Institute Limited - Employee Stock Option Plan 2022
Intimation for Earnings Call audio recording - May 17, 2023
Related Party Disclosures - Reg 23(9)_March 31, 2023
ESOP Allotment - May 16, 2023
SE Intimation for Agreement to sell for acquisition of land and building situated in Uttar Pradesh by Crosslay Remedies Limited, wholly-owned subsidiary
Board Meeting Intimation - May 16, 2023
SE Intimation for update on petition filed by the Company against Touch Healthcare Private Limited and Others
SE Intimation for Petition filed by the Company against Touch Healthcare Private Limited and Others
MHIL – Disclosure under Large Corporate Entity – FY 2023
SE intimation for Additional details w.r.t. resignation of Ms. Harmeen Mehta (DIN: 02274379) from the position of Independent Woman Director
ESOP Allotment – April 18, 2023
SE Intimation for resignation of Ms. Harmeen Mehta (Independent Director)
MHIL SEs Intimation Regulation 30 – Acquisition of additional equity stake in Eqova Healthcare Private Limited - April 13, 2023
Compliance under Regulation 40(9) of the SEBI LODR Regulations – March 31, 2023
Compliance under Regulation 76 of the SEBI (DP) Regulations – March 31, 2023
Compliance under Regulation 7(3) of the SEBI LODR Regulations – March 31, 2023
Compliance under Regulation 74(5) of the SEBI (DP) Regulations – March 31, 2023
Trading window Closure: March 31, 2023
ESOP Allotment - March 16, 2023
Intimation for contact details of Company Secretary and Compliance Officer
Intimation for earnings call audio recording – February 03, 2023
Appointment of Mr. Dhiraj Aroraa as Company Secretary and Compliance Officer
ESOP Allotment - February 02, 2023
Update on Board Meeting for fund raising – February 02, 2023
Compliance under Regulation 76 of the SEBI (DP) Regulations – December 31, 2022
Board Meeting Intimation- February 02, 2023
Compliance under Regulation 74(5) of the SEBI (DP) Regulations - December 31, 2022
Allotment of ESOP – January 18, 2023
Closure of Trading Window – December 31, 2022
Corrigendum for Intimation filed on December 15, 2022 for Nanavati Expansion
Intimation for ESOP Allotment- December 15, 2022
Stock Exchange Intimation for Nanavati Expansion
Intimation for Allotment of ESOP
Intimation for Submission of Application for reclassification from Promoter to Public
Related Party Disclosures - Regulation 23(9)_September 30, 2022
Transcript of Earnings Call - Q2 and H1 FY23
Intimation for Investor Conference
Intimation for Earning Call audio recording - Q2 FY23
Intimation for reclassification from Promoter to Public (Extracts of minutes)
Intimation regarding allotment of ESOP
Intimation for Earning Call - November 02, 2022
Intimation regarding Board Meeting - November 01, 2022
Compliance under Regulation 76 of the SEBI (DP) Regulations - September 30, 2022
Compliance under Regulation 74(5) of the SEBI (DP) Regulations - September 30, 2022
Re-classification of Promoter to Public category
SE Intimation for Resignation of Company Secretary & Compliance Officer
Closure of Trading Window - Sep 30, 2022
Voting results and Scrutinizer Report - 21 AGM
Intimation regarding Investor Meet - Sep 29, 2022
SE Intimation for resignation of Prashant Kumar
Intimation Regarding Investor Conference- Sep 19, 2022
Intimation regarding allotment of Equity Share under MHIL ESOP Scheme-2020
Intimation Regarding Investor Conference- Sep 08, 2022
Intimation Regarding Investor Conference- Sep 07, 2022
SE intimation regarding revision in Credit Ratings of Max Healthcare Institute Limited and its Material Subsidiaries
SE intimation relating to distribution of business undertaking of Saket City Hospitals to Max Healthcare Institute Limited
SE Intimation regarding Appointment of Mr. Anil Bhatnagar as Non Executive Non- Independent Director and revision in term of re-appointment of Mr. Abhay Soi as Chairman and Managing Director
SE Intimation for resignation of Gaurav Trehan
Transcript of Earnings call - Q1’FY23
Earning call audio recording Intimation – Q1 FY23
Notice_of_Board_Meeting- August 10, 2022
2022/07/18 Stock Exchange Intimation - Livemint Article
Compliance under Regulation 76 of the SEBI (DP) Regulations - June 30, 2022
Compliance under Regulation 74(5) of the SEBI (DP) Regulations - June 30, 2022
Closure of trading window- June 30, 2022
SE intimation relating to Voluntary Liquidation of Saket City Hospitals Limited
Related Party Disclosure- Reg-23(9)_March 31, 2022
SE intimation relating to Crosslay Remedies Limited becoming Wholly Owned Subsidiary of Max Healthcare Institute Limited
Transcript Earnings Call- Q4 FY22
Annual Secretarial Compliance Report – FY 21-22
Notice of Board Meeting - May 25, 2022
Merger of Alps Hospital Limited with Max Hospitals and Allied Services Limited
MHIL - Disclosure under Large Corporate Entity FY 22
Compliance under Regulation 76 of the SEBI (DP) Regulations - March 31, 2022
Compliance under Regulation 40(9)- March 31, 2022
Compliance under Regulation 7(3) of the SEBI LODR Regulations- March 31, 2022
Compliance under Regulation 74(5) of the SEBI (DP) Regulations- March 31, 2022
Nomination of Independent Director on the Board of Crosslay Remedies Limited
Closure of Trading window-March 31, 2022
Intimation of approval for reclassification of certain shareholders from ‘Promoter’ category to ‘Public’ category
Resignation of Ms. Ananya Tripathi and Appointment of Mr. Gaurav Trehan
MHIL SEs Intimation Regulation 30 – Acquisition of equity stake in Eqova Healthcare Private Limited
Board Meeting intimation February 12, 2022
MHIL SEs Intimation Regulation 30 – Long term services agreement with Muthoot Hospitals Private Limited
Compliance under Regulation 76 of the SEBI (DP) Regulations - Dec 31, 2021
MHIL SE Intimation - Financial Impact of VRS
Compliance under Regulation 74(5) of the SEBI (DP) Regulations- Dec 31, 2021
Closure of Trading Window - Dec 31, 2021
Voluntary liquidation of Saket City Hospitals Limited
Re-classification of certain Promoters to Public category- Stock Exchange Application Intimation
Re-classification of certain Promoters to PUBLIC from PROMOTERS
Intimation under Regulation 30, withdrawal of Merger between ALPS & SCHL
ESOP Grant 2021
Scrutinizer’s Report and Postal Ballot voting result Nov 2021
Board Meeting Intimation - November 12, 2021
Board Approval - Amendment in AOA & Conducting Postal Ballot
SAST - Annexure II - Pledge by Kayak
Compliance under 74(5) of the SEBI (DP) Regulations - Sept 30, 2021
Compliance under 76 of the SEBI (DP) Regulations - Sept 30, 2021
Compliance under 74(5) of the SEBI (DP) Regulations - June 30, 2021
Compliance under 76 of the SEBI (DP) Regulations - June 30, 2021
Updates - 1000 beds addition in Gurugram
Voting Result & Scrutnizer's Report- 20th AGM
Closure of Trading Window - Sept 30, 2021
MHIL intimation for amendment to the SHA Dec 24, 2018
MHIL Intimation for Change in Date of 20th AGM
MHIL SEs Intimation of VRS in Nanavati
Intimation to Stock Exchange - Acquisition of ET Planners Pvt Ltd through ALPS Hospital Ltd
Intimation to Stock Exchanges_additional investment in Alps Hospitals Limited (WoS)
Completion of Open Market Sale by Promoters for achieving MPS
Intimation to Stock Exchange – Open Market Sale
SEBI Approval Letter – Open Market Sale/MPS Threshold
Announcement under Regulation 30 of SEBI (LODR) corporate guarantee
Board Meeting Intimation - August 10, 2021
Revision in Credit Rating Intimation
Closure of Trading Window - June 30, 2021
Related Party Disclosure - Reg 23(9) _March 31, 2021
Annual Secretarial Compliance Report - FY 20-21
Disclosure under Regulation 4(1) of PIT Regulations 2015
Appointment of Ms. Harmeen Mehta, as Non- Executive Independent Director
Board Meeting Intimation - May 28, 2021
Compliance under Regulation 74(5) of the SEBI (DP) Regulations- March 31, 2021
Compliance under regulation 40(9)- March 31, 2021
Compliance under Regulation 7(3) - March 31, 2021 BSE
Compliance under Regulation 76 of the SEBI (DP) Regulations- March 31, 2021
Compliance under regulation 40(9)- March 31, 2021
SE intimation on Intimation of placing of matter before the Board of Directors
SE intimation on Intimation of proposed formation of a wholly owned subsidiary
SE intimation on Acquisition of Stake in Crosslay Remedies Limited
Closure of Trading Window - March 31, 2021
SE intimation on Acquisition of Stake in Saket City Hospitals Ltd
SE Intimation Relating to List of Allottees
SE intimation relating to Allotment of equity shares of face value of INR 10 each (“Equity Shares”)
SE intimation relating to approval and adoption of the placement document dated March 9, 2021
SE Intimation March 09 2021
Regulation 30 & 29 Announcement Outcome of QIP
Regulation 30 Performa Financial Information & Special Purpose Consolidated Financial Information
Board Meeting intimation- 27.01.2021
Reconciliation of Share Capital Audit Report– December 31, 2020
Certificate under regulation 74(5) of DP Regulations–December 31, 2020
Closure of trading Window- December 31, 2020
Announcement Under Regulation 30 (LODR)-Code Of Conduct Under SEBI (PIT) Regulations, 30.12.2020
Certificate under regulation 74(5) of DP Regulations– September 2020- 20.10.2020
Compliance Under Regulation 40(9)– September 2020-19.10.2020
Certificate under regulation 7(3)– September 2020- 19.10.2020
Reconciliation of Share Capital Audit Report– Sept 20, 2020
Compliance under Reg 23(9)- December 09, 2020
Board Meeting intimation- 30-10-2020
Credit Rating Intimation
Closure of trading Window- September 30, 2020
Voting result & Scrutinizer’s Report- AGM
Grant of ESOP
Intimation of Completion of Open market sale of Equity shares
Intimation for open market sale of equity shares
Stx Intimation- Notice of AGM
Intimation regarding AGM timings
Intimation of Amendments to the Articles of Association
Intimation to Stx - Annual Report
Board Meeting Intimation – August 26, 2020
Announcement Under Regulation 30 (LODR)-Code Of Conduct Under SEBI (PIT) Regulations, 2015
Board Meeting Intimation - February 06, 2021